Focused Shock Wave
The FDA Approved Focused Shock Wave is the next generation of ESWT Extracorporeal Shock Wave Treatment with patented focused “Cylindrical Source“ Technology available from CuraMedix.
This unique device leads the industry in innovation and performance for the treatment of pain associated with chronic proximal plantar fasciitis.
How it Works:
This Focused Shock Wave device uses an electromagnetically generated shock wave produced within a hand-held applicator (F-SW Hand piece). The shock wave is generated by discharging a high voltage capacitor located in the control unit into a cylindrically shaped coil system in the handpiece which is surrounded by a cylindrical metallic membrane. The transient magnetic field produced by the coil induces eddy currents in the metal membrane, causing it to repel from the coil, producing a pressure wave. The membrane is immersed in water and the pressure wave produced by the membrane propagates through the water to a concentric parabolic reflector, where it is reflected to a focal point outside of the handpiece in front of the reflector.
With its progressive technological advancements, Extracorporeal Pulse Activation Technology (EPAT/ESWT) delivers an evidence-based*, non-surgical solution for patients suffering from chronic heel pain. It addresses the increasing demand for patient convenience, less down-time and risk, as well as better clinical and economic outcomes, and improved practice efficiencies and cash-flow.
Health care professionals are using EPAT/ESWT to successfully treat acute or chronic musculoskeletal pain and/or pain that significantly impairs mobility or quality of life. Areas include:
- Foot and ankle
- Lower extremity
- Upper extremity
- Back and chest
- Myofascial trigger points
Is focused ESWT effective in relieving chronic heel pain diagnosed as plantar fasciitis?
Check out the study published in The Journal of Bone & Joint Surgery “Clinically relevant effectiveness of focused extracorporeal shock wave therapy in the treatment of chronic plantar fasciitis: a randomized, controlled multicenter study.”
DOWNLOAD THE STUDY
For more information, to schedule a demo or to discuss pricing, please call 877-699-8399.